Literature DB >> 21296539

Pan-aortic hybrid treatment of mega-aorta syndrome.

Asad A Shah1, Syamal D Bhattacharya, Richard L McCann, G Chad Hughes.   

Abstract

Hybrid procedures combining traditional open and newer endovascular techniques are increasingly used to treat complex aortic disease. We present a novel approach for total aortic replacement, including hybrid repair of the arch and thoracoabdominal aorta, in a patient with "mega-aorta syndrome." A two-stage approach using a valve-sparing aortic root replacement, total arch replacement (stage I elephant trunk), and left carotid-axillary bypass was used to treat the root, proximal-mid arch, and left subclavian aneurysmal pathology. This was followed by a hybrid distal arch/Extent II thoracoabdominal aneurysm repair 3 months later. After 15 months follow-up, the patient remains asymptomatic with an intact repair, no endoleak, and normal ventricular and aortic valve function. This case demonstrates a novel "pan-aortic" hybrid approach for repair of extensive thoracic aortic disease.
Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21296539     DOI: 10.1016/j.jvs.2010.11.115

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  2 in total

1.  Hybrid three-stage repair of mega aorta with Lupiae technique: tips and tricks.

Authors:  Giampiero Esposito; Antonio Pignatelli; Gaetano Contegiacomo; Giangiuseppe Cappabianca; Cesare Beghi; Carlo Lafranceschina; Fabio Tiecco; Francesco Bartolomucci; Matteo Miccoli; Massimiliano Conte
Journal:  Ann Cardiothorac Surg       Date:  2018-05

2.  Current management and outcome of chronic type B aortic dissection: results with open and endovascular repair since the advent of thoracic endografting.

Authors:  Nicholas D Andersen; Jeffrey E Keenan; Asvin M Ganapathi; Jeffrey G Gaca; Richard L McCann; G Chad Hughes
Journal:  Ann Cardiothorac Surg       Date:  2014-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.